BMC Medical Genetics has published it’s 500th article today, the 11th BMC-series journal to reach this milestone. BMC Medical Genetics has moved from strength to strength since its launch in November 2000: submissions to the journal have grown rapidly, the journal has published a supplement by the Framingham Heart Study, and the journal received its… Read more »
Following the announcement last month of the success of the HIV-1 vaccine clinical trial, RV144, Ben Berkhout and William Paxton discuss the implications of this positive vaccine efficacy in their Editorial, published today in Retrovirology. The RV144 Clinical trial began in 2003 and was seen by many as being a non-starter due to each of… Read more »
When a genomic research project is planned, its medical applications may not be immediately apparent, and the subsequent process of translation to the clinic may be fraught with difficulties. Two new Correspondence articles in Genome Medicine provide insights into the challenges of moving systems biology research towards clinical utility, and the advance steps that can… Read more »
In June 2009, BMC Medicine received its first “official” impact factor from Thomson Reuters of 3.28. To mark this landmark occasion, the BMC Medicine editorial team outline their vision and aims for the journal for the future in an editorial published this week. BMC Medicine aims to act as a conduit to connect biomedical researchers,… Read more »
"ChIP’ing the mammalian genome: technical advances and insights into functional elements", a Review recently published in Genome Medicine, examines the power of chromatin immunoprecipitation methods for genomic studies. Chromatin immunoprecipitation, or ChIP, cross-links DNA with its associated proteins before using specific antibodies to precipitate whichever protein is of interest, bringing with it the attached DNA… Read more »